Vianna JS et al. |
The interplay between mutations in cagA, 23S rRNA, gyrA and drug resistance in Helicobacter pylori. |
2018 |
Rev. Inst. Med. Trop. Sao Paulo |
pmid:29972462
|
Myojin S et al. |
Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child. |
2018 |
Int. J. Infect. Dis. |
pmid:29966711
|
Liou JM et al. |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection. |
2018 |
Gastroenterology |
pmid:29964036
|
Kwofie SK et al. |
Screening of Isocitrate Lyase for Novel Anti-Buruli Ulcer Natural Products Originating from Africa. |
2018 |
Molecules |
pmid:29954088
|
Tanabe H et al. |
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication. |
2018 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:29950163
|
Sandri A et al. |
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice. |
2018 |
Virulence |
pmid:29938577
|
Gonzalez-Hormazabal P et al. |
Prevalence of clarithromycin resistance in Helicobacter pylori in Santiago, Chile, estimated by real-time PCR directly from gastric mucosa. |
2018 |
BMC Gastroenterol |
pmid:29925321
|
Fiorini G et al. |
Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice. |
2018 |
Eur J Gastroenterol Hepatol |
pmid:29481383
|
Talarico S et al. |
High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR. |
2018 |
Helicobacter |
pmid:29480566
|
Takemori N et al. |
A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus - clinical significance and possible mechanisms: a case report. |
2018 |
J Med Case Rep |
pmid:29454372
|
Xu R et al. |
Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban. |
2018 |
Eur. J. Clin. Pharmacol. |
pmid:29453492
|
Tsutsui A et al. |
Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016. |
2018 |
J. Infect. Chemother. |
pmid:29428566
|
Zagari RM et al. |
Treatment of Helicobacter pylori infection: A clinical practice update. |
2018 |
Eur. J. Clin. Invest. |
pmid:29144559
|
Liu DS et al. |
Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study. |
2018 |
Clin. Microbiol. Infect. |
pmid:29138101
|
Redondo JJ et al. |
A novel RT-PCR for the detection of Helicobacter pylori and identification of clarithromycin resistance mediated by mutations in the 23S rRNA gene. |
2018 |
Diagn. Microbiol. Infect. Dis. |
pmid:29111147
|
Iwamoto J et al. |
Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease. |
2018 |
Intern. Med. |
pmid:29093413
|
Inagaki Y et al. |
Disseminated Cutaneous Infection of Mycobacterium colombiense in a Patient with Myelodysplastic Syndrome. |
2018 |
Intern. Med. |
pmid:29093379
|
De Francesco V et al. |
Quadruple, sequential, and concomitant first-line therapies for H. pylori eradication: a prospective, randomized study. |
2018 |
Dig Liver Dis |
pmid:29089267
|
Ullah S et al. |
Hydrophilically modified self-assembling α-tocopherol derivative as niosomal nanocarrier for improving clarithromycin oral bioavailability. |
2018 |
Artif Cells Nanomed Biotechnol |
pmid:28541761
|
Cheung KS et al. |
Long-term proton pump inhibitors and risk of gastric cancer development after treatment for : a population-based study. |
2018 |
Gut |
pmid:29089382
|